| Literature DB >> 33907280 |
Fen Tang1, Fan Xu2, Ning Su1, Lingjuan Liu1, Li Jiang1, Ningning Tang1, Xin Zhao1, Ling Cui1, Siming Zeng1, Zhaoguang Lai1, Min Li3, Haibin Zhong4.
Abstract
Air injection is an accessory technique during scleral buckling (SB). Subclinical subretinal fluid (SRF) may presence and persistent after SB. The impact of air injection on SRF is unclear. In the study, we retrospectively enrolled 51 patients with macular-involving RD who had undergone successful SB. They were categorized into Group A (SB without air injection) and Group B (SB with air injection). First, we found that although group B seem to be severer than group A before surgery, Kaplan-Meier graph showed that SRF absorbed more rapidly in group B after surgery, and the incidence of SRF in group B was much lower during the whole follow-up period. Moreover, the cases with superior breaks had the lowest incidence. Second, during the follow-up period, there was no significant difference about postoperative complication between two groups. Lastly, risk factors for persistent SRF were investigated with binary logistic regression, and no risk factor was found. In conclusion, air injection during the SB might accelerate SRF absorption and reduce the incidence of persistent SRF, especially for the longstanding macular-off RD with superior breaks.Entities:
Year: 2021 PMID: 33907280 PMCID: PMC8079402 DOI: 10.1038/s41598-021-88670-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patients’ demographic and preoperative clinical characteristics.
| Group A (n = 28) | Group B (n = 23) | ||
|---|---|---|---|
| 37.82 ± 14.07 | 43.96 ± 17.07 | 0.166a | |
| 9 (32.14%) | 9(39.13%) | 0.751b | |
| 17.89 ± 10.97 | 30.74 ± 31.22 | 0.252c | |
| 0.82 ± 0.35 | 1.14 ± 0.23 | 0.003a | |
| 14.11 ± 3.26 | 12.23 ± 2.38 | 0.025a | |
| 0.425d | |||
| 1 break | 22 (78.6%) | 14 (60.9%) | |
| 2 breaks | 3 (10.7) | 6 (26.1%) | |
| 3 breaks | 1 (3.6%) | 2 (8.7%) | |
| 4 breaks | 2 (7.1%) | 1 (4.3%) | |
| 1.000d | |||
| Tractional tear | 24 (85.7%) | 20 (87.0%) | |
| Atrophic hole | 2 (7.15%) | 1 (4.3%) | |
| Both | 2 (7.15%) | 2 (8.7%) | |
| 0.177d | |||
| Superior | 11 (39.3%) | 13 (56.5%) | |
| Inferior | 13 (46.4%) | 5 (21.7%) | |
| Both | 4 (14.3%) | 5 (21.7%) | |
| 0.152d | |||
| 1 quadrant | 9 (32.1%) | 5 (21.7%) | |
| 2 quadrants | 15 (53.6%) | 12 (52.2) | |
| 3 quadrants | 4 (14.3%) | 2 (8.7%) | |
| 4 quadrants | 0 (0%) | 4 (17.4%) | |
| 0.009d | |||
| A | 2 (7.1%) | 1 (4.3%) | |
| B | 16 (57.1%) | 5 (21.7%) | |
| C1 | 10 (35.7%) | 13 (56.6%) | |
| C2 | 0 (0%) | 4 (17.4%) | |
| Diabetes | 1 | 2 | 0.583d |
| Hypertension | 2 | 2 | 1.0d |
at-test.
bChi-square test.
cMann-Whitney U test.
dFisher exact test,
Abbreviation: BCVA, Best Corrected Visual Acuity; IOP, Intraocular Pressure; PVR, Proliferative vitreoretinopathy.
Figure 1The distribution of retinal detachment features. The number of retinal breaks was evaluated and determined by three consultants. The superior break was defined as a tear present between 9 to 3 o’clock, while an inferior break was defined as a tear present between 3 to 9 o’clock. The extent was determined with the clocks of detachment, the extent less than 3 clocks was defined as 1 quadrant, the extent between 3 to 6 clocks was defined as 2 quadrants, the extent between 6 to 9 clocks was defined as 3 quadrants, and the extent between 9 to 12 clocks was defined as 4 quadrants. The grade of PVR was determined according to the classification from the American Retina Terminology Committee (1983).
The information of buckle configuration during surgery.
| Group A (n = 28) | Group B (n = 23) | ||
|---|---|---|---|
| 100% | 100% | ||
| 16.71 ± 3.63 | 17.35 ± 3.47 | 0.530a | |
| 0.154b | |||
| Viscous | 3 (10.71%) | 7 (30.43%) | |
| Clear | 25(89.29%) | 16(69.57%) |
at-test.
bFisher exact test.
Figure 2Kaplan–Meier survival curve illustrating the rate of SRF against time for group A (SB without air injection) and group B (SB with air injection). The incidence of SRF was significantly different (p < 0.001, log-rank test).
Comparison of persistent SRF at postoperative 24 weeks in patients with different location of breaks.
| Location of breaks | Subjects | Persistent SRF | ||
|---|---|---|---|---|
| Group A | Superior break | 12 | 3 | 0.292a |
| Inferior break | 10 | 4 | ||
| Both | 6 | 4 | ||
| Group B | Superior break | 13 | 0 | 0.012*a |
| Inferior break | 5 | 1 | ||
| Both | 5 | 3 |
aFisher exact test.
Postoperative clinical characteristics and complications.
| Group A (n = 28) | Group B (n = 23) | ||
|---|---|---|---|
| Primary reattachment (%) | 100% | 100% | |
| BCVA (Log MAR) | 0.35 ± 0.17 | 0.41 ± 0.14 | 0.33a |
| IOP (mmHg) | 15.76 ± 2.04 | 15.20 ± 2.26 | 0.57a |
| The events of elevated IOP | |||
| > 21 mmHg | 5 | 4 | |
| > 30 mmHg | 1 | 1 | |
| > 40 mmHg | 0 | 0 | |
| The epiretinal membrane | 0 | 0 | |
| Complicated cataract | 0 | 0 | |
| New retinal tear | 0 | 0 | |
| Bleeding | 0 | 0 | |
| Choroidal detachment | 0 | 0 | |
at-test.
BCVA, Best Corrected Visual Acuity; IOP, Intraocular Pressure.
Binary logistic regression of risk factors for persistent SRF at postoperative 24 weeks.
| Factors | OR (95%CI) | |
|---|---|---|
| Gender | 14.96 (0.28–589.46) | 0.149 |
| Age* | 0 (0–0) | 0.309 |
| Disease chronicity# | 0.088 (0.001–12.814) | 0.633 |
| Diabetes | 0.019 (0–17.88) | 0.258 |
| Hypertension | 0.266 (0.006–11.593) | 0.266 |
| Preoperative BCVA | 0.002 (0–4.503) | 0.114 |
| Preoperative IOP- | 1.2 (0.813–1.771) | 0.358 |
| The PVR grading | 0.151 (0.001–16.78) | 0.432 |
Age*: Level 1, below 30 yrs; Level 2, above 30 yrs and below 60 yrs; Level 3, above 60 yrs.
Disease chronicity#: Acute: symptom duration < = 7 days; Subacute: symptom duration > 7 days and < = 30 days; Chronic: symptom duration > 30 days.
OR, odd ration; CI, confidence interval.